These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30625298)

  • 1. Innovative Trial Designs in GI Drug Development: Why Trials Succeed and Fail-A Brief Report From 2018 Digestive Disease Week.
    Harris MS; Howden CW
    Gastroenterology; 2019 Apr; 156(5):1239-1242. PubMed ID: 30625298
    [No Abstract]   [Full Text] [Related]  

  • 2. Current Challenges and Emerging Solutions in Upper GI Disorders: A Brief Report of the 2016 AGA Drug Development Conference.
    Howden CW; Vakil NB
    Gastroenterology; 2017 Mar; 152(4):e1-e4. PubMed ID: 28147223
    [No Abstract]   [Full Text] [Related]  

  • 3. One size fits one: pharmacogenetics in gastroenterology.
    Porayette P; Flockhart D; Gupta SK
    Clin Gastroenterol Hepatol; 2014 Apr; 12(4):565-70. PubMed ID: 24486737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accessing Food and Drug Administration Resources in Clinical Practice: A Primer for the Practicing Gastroenterologist.
    Shah ED; Beaulieu DB; Yacyshyn B;
    Am J Gastroenterol; 2019 Oct; 114(10):1688-1690. PubMed ID: 31464738
    [No Abstract]   [Full Text] [Related]  

  • 5. Meeting Report: AGA Biosimilars Roundtable.
    Howden CW; Lichtenstein GR
    Gastroenterology; 2018 Apr; 154(5):e1-e5. PubMed ID: 29510132
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prokinetic drugs in gastroenterology].
    Galmiche JP; Bruley des Varannes S; Le Bodic L
    Gastroenterol Clin Biol; 1991; 15(2 ( Pt 3)):T7-10. PubMed ID: 2065903
    [No Abstract]   [Full Text] [Related]  

  • 7. Gastrointestinal motility and perception disorders re-visited.
    Malagelada JR
    Rev Esp Enferm Dig; 2004 Jul; 96(7):477-80, 481-4. PubMed ID: 15283630
    [No Abstract]   [Full Text] [Related]  

  • 8. Cannabinoids as gastrointestinal anti-inflammatory drugs.
    Fabisiak A; Fichna J
    Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 28239924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Octreotide (Famsynthesis): new possibilities in gastroenterology].
    Velichko MA; Vreshch VD
    Voen Med Zh; 2001 May; 322(5):44-5. PubMed ID: 11550331
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastroenterology--15th United European Week. New developments in the treatment of GERD and GI disorders.
    Tack J
    IDrugs; 2008 Jan; 11(1):33-5. PubMed ID: 18175260
    [No Abstract]   [Full Text] [Related]  

  • 11. Digestive Disease Week 2005. Drug highlights II.
    De La Rue SA
    IDrugs; 2005 Jul; 8(7):539-41. PubMed ID: 15973558
    [No Abstract]   [Full Text] [Related]  

  • 12. Drugs targeting functional bowel disorders: lessons from drug trials.
    Camilleri M
    Curr Opin Pharmacol; 2002 Dec; 2(6):684-90. PubMed ID: 12482731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The trials and tribulations of drug development for functional gastrointestinal disorders.
    Chang L
    Neurogastroenterol Motil; 2008 May; 20 Suppl 1():130-8. PubMed ID: 18402650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Problems of long-term therapy and therapeutic damage considering the clinical aspects. Gastroenterology].
    Dölle W
    Verh Dtsch Ges Inn Med; 1991; 97():63-70. PubMed ID: 1808956
    [No Abstract]   [Full Text] [Related]  

  • 15. How Failure Can Fuel Improvements in Early Drug Development for Inflammatory Bowel Diseases.
    Schreiber S; Vermeire S
    Gastroenterology; 2016 May; 150(5):1061-1066. PubMed ID: 27018485
    [No Abstract]   [Full Text] [Related]  

  • 16. Biomarker and drug discovery for gastroenterology through translational bioinformatics.
    Dudley JT; Butte AJ
    Gastroenterology; 2010 Sep; 139(3):735-41, 741.e1. PubMed ID: 20650279
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA Town Hall-New Drug Approvals in Gastrointestinal Disease (2018-2019).
    Harris MS; Howden CW;
    Gastroenterology; 2020 Jan; 158(1):18-21. PubMed ID: 31626755
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficient Early Drug Development for Ulcerative Colitis.
    Khanna R; Jairath V; Vande Casteele N; Mosli MH; Zou G; Parker CE; Levesque BG; Sandborn WJ; D'Haens G; Feagan BG
    Gastroenterology; 2016 May; 150(5):1056-1060. PubMed ID: 27018491
    [No Abstract]   [Full Text] [Related]  

  • 19. [Causes of functional digestive disorders and therapeutic approach in primary care medicine].
    Coman AE; Popa E; Grigore C; Maidaniuc M; Petrovanu R
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):75-9. PubMed ID: 20509279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moving ahead or falling behind?
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2007 Jun; 4(6):295. PubMed ID: 17541443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.